Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (170)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by SCHILDKRAUT, J. M.
Right arrow Articles by THOMPSON, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHILDKRAUT, J. M.
Right arrow Articles by THOMPSON, W. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 128, No. 3: 456-466
Copyright © 1988 by The Johns Hopkins University School of Hygiene and Public Health


research-article

FAMILIAL OVARIAN CANCER: A POPULATION-BASED CASE-CONTROL STUDY1

JOELLEN M. SCHILDKRAUT and W. DOUGLAS THOMPSON

Reprint requests to Dr. W. Douglas Thompson

Data from a multicenter population-based case-control study were analyzed to assess the degree of aggregation of ovarian cancer in families. Included as cases were 493 women aged 20–54 who had been newly diagnosed with epithelial ovarian cancer. The frequency with which cases reported a family history of ovarian cancer was compared with the frequency for a group of 2,465 controls selected by random digit dialing. The odds ratios for ovarian cancer in first- and second-degree relatives were 3.6 (95% confidence interval (CI) 1.8–7.1) and 2.9 (95% CI 1.6–5.3), respectively, compared with women with no family history of ovarian cancer. The null hypothesis of no association was excluded on both the maternal and paternal sides of the families studied. Ovarian cancer in relatives was reported by women with malignant lesions but not by women with borderline lesions. These results did not seem to be attributable to the possible confounding effects of any of several covariates or to errors in reporting family history of ovarian cancer.

family; genetics; histology; ovarian neoplasms


1 From the Department of Epidemiology and Public Health, Yale University School of Medicine, 60 College Street, New Haven, CT 06510.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Med Decis MakingHome page
K. Tiller, B. Meiser, C. Gaff, J. Kirk, T. Dudding, K.-A. Phillips, M. Friedlander, and K. Tucker
A Randomized Controlled Trial of a Decision Aid for Women at Increased Risk of Ovarian Cancer
Med Decis Making, July 1, 2006; 26(4): 360 - 372.
[Abstract] [PDF]


Home page
Cancer Res.Home page
M. Moscova, D. J. Marsh, and R. C. Baxter
Protein Chip Discovery of Secreted Proteins Regulated by the Phosphatidylinositol 3-Kinase Pathway in Ovarian Cancer Cell Lines
Cancer Res., February 1, 2006; 66(3): 1376 - 1383.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. A. Cannistra
Cancer of the Ovary
N. Engl. J. Med., December 9, 2004; 351(24): 2519 - 2529.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Berchuck, J. M. Schildkraut, R. M. Wenham, B. Calingaert, S. Ali, A. Henriott, S. Halabi, G. C. Rodriguez, D. Gertig, D. M. Purdie, et al.
Progesterone Receptor Promoter +331A Polymorphism is Associated with a Reduced Risk of Endometrioid and Clear Cell Ovarian Cancers
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2141 - 2147.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
V. McGuire, A. Felberg, M. Mills, K. L. Ostrow, R. DiCioccio, E. M. John, D. W. West, and A. S. Whittemore
Relation of Contraceptive and Reproductive History to Ovarian Cancer Risk in Carriers and Noncarriers of BRCA1 Gene Mutations
Am. J. Epidemiol., October 1, 2004; 160(7): 613 - 618.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. S. Piver
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate
Oncologist, October 1, 1996; 1(5): 326 - 330.
[Full Text] [PDF]


Home page
JAMAHome page
W. Foulkes, G. Glendon, and S. Narod
Family History and Risk of Ovarian Cancer
JAMA, August 2, 1995; 274(5): 383 - 383.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
R. A. Kerber and M. L. Slattery
The Impact of Family History on Ovarian Cancer Risk: The Utah Population Database
Arch Intern Med, May 8, 1995; 155(9): 905 - 912.
[Abstract] [PDF]


Home page
NEJMHome page
S. A. Cannistra
Cancer of the Ovary
N. Engl. J. Med., November 18, 1993; 329(21): 1550 - 1559.
[Full Text]


Home page
NEJMHome page
A. Oldenhave, P. M. Gocze, W. W. Patton, K. J. Carlson, D. H. Nichols, and I. Schiff
Indications for Hysterectomy
N. Engl. J. Med., July 22, 1993; 329(4): 275 - 276.
[Full Text]


Home page
JAMAHome page
M.-C. King, S. Rowell, and S. M. Love
Inherited Breast and Ovarian Cancer: What Are the Risks? What Are the Choices?
JAMA, April 21, 1993; 269(15): 1975 - 1980.
[Abstract] [PDF]


Home page
JAMAHome page
C. I. Amos, G. L. Shaw, M. A. Tucker, and P. Hartge
Age at Onset for Familial Epithelial Ovarian Cancer
JAMA, October 14, 1992; 268(14): 1896 - 1899.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.